| Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer J Peng, S Sengupta, VC Jordan Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2009 | 165 | 2009 |
| Anticancer Agents Med BP Teng Chem 11, 620-628, 2011 | 121* | 2011 |
| Molecular Mechanism of Action of Bisphenol and Bisphenol‐A Mediated by Estrogen Receptor alpha in Growth and Apoptosis of Breast Cancer Cells S Sengupta, I Obiorah, PY Maximov, R Curpan, VC Jordan British Journal of Pharmacology, 2013 | 111 | 2013 |
| Estrogen regulation of X-box binding protein-1 and its role in estrogen induced growth of breast and endometrial cancer cells S Sengupta, CGN Sharma, VC Jordan Hormone molecular biology and clinical investigation 2 (2), 235-243, 2010 | 86 | 2010 |
| Selective Estrogen Modulators as an Anticancer Tool S Sengupta, VC Jordan Innovative Endocrinology of Cancer, 206-219, 2008 | 80 | 2008 |
| Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells WR Harrington, S Sengupta, BS Katzenellenbogen Endocrinology 147 (8), 3843-3850, 2006 | 78 | 2006 |
| Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: A potential clinical … RR Patel, S Sengupta, HR Kim, AJ Klein-Szanto, JR Pyle, F Zhu, T Li, ... European Journal of Cancer 46 (9), 1537-1553, 2010 | 55 | 2010 |
| Attainment of peak bone mass and bone turnover rate in relation to estrous cycle, pregnancy and lactation in colony-bred Sprague–Dawley rats: suitability for studies on … S Sengupta, M Arshad, S Sharma, M Dubey, MM Singh The Journal of steroid biochemistry and molecular biology 94 (5), 421-429, 2005 | 54 | 2005 |
| Cyclin dependent kinase-9 mediated transcriptional de-regulation of cMYC as a critical determinant of endocrine-therapy resistance in breast cancers S Sengupta, MC Biarnes, VC Jordan Breast cancer research and treatment 143, 113-124, 2014 | 52 | 2014 |
| Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells S Sengupta, R Schiff, BS Katzenellenbogen Breast cancer research and treatment 117, 243-251, 2009 | 46 | 2009 |
| Inhibition of BET proteins impairs estrogen-mediated growth and transcription in breast cancers by pausing RNA polymerase advancement S Sengupta, MC Biarnes, R Clarke, VC Jordan Breast cancer research and treatment 150, 265-278, 2015 | 42 | 2015 |
| Lipin1 regulation by estrogen in uterus and liver: implications for diabetes and fertility PM Gowri, S Sengupta, S Bertera, BS Katzenellenbogen Endocrinology 148 (8), 3685-3693, 2007 | 40 | 2007 |
| Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression PSN Murthy, S Sengupta, S Sharma, MM Singh The Journal of steroid biochemistry and molecular biology 100 (4-5), 117-128, 2006 | 37 | 2006 |
| In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague–Dawley rats by ormeloxifene, a selective estrogen receptor modulator M Arshad, S Sengupta, S Sharma, R Ghosh, V Sawlani, MM Singh The Journal of steroid biochemistry and molecular biology 91 (1-2), 67-78, 2004 | 37 | 2004 |
| Endoxifen, 4-hydroxytamoxifen and an estrogenic derivative modulate estrogen receptor complex mediated apoptosis in breast cancer PY Maximov, B Abderrahman, SW Fanning, S Sengupta, P Fan, ... Molecular pharmacology 94 (2), 812-822, 2018 | 30 | 2018 |
| Defining the Conformation of the Estrogen Receptor Complex That Controls Estrogen-Induced Apoptosis in Breast Cancer I Obiorah, S Sengupta, R Curpan, VC Jordan Molecular pharmacology 85 (5), 789-799, 2014 | 30 | 2014 |
| Delayed triggering of oestrogen induced apoptosis that contrasts with rapid paclitaxel-induced breast cancer cell death I Obiorah, S Sengupta, P Fan, VC Jordan British journal of cancer 110 (6), 1488-1496, 2014 | 30 | 2014 |
| Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in anti-hormone resistance GM Balaburski, RC Dardes, M Johnson, B Haddad, F Zhu, EA Ross, ... International journal of oncology 37 (2), 387-398, 2010 | 30 | 2010 |
| Pnck overexpression in HER-2 gene-amplified breast cancer causes Trastuzumab resistance through a paradoxical PTEN-mediated process TB Deb, AH Zuo, RJ Barndt, S Sengupta, R Jankovic, MD Johnson Breast Cancer Research and Treatment 150, 347-361, 2015 | 25 | 2015 |
| Pnck induces ligand-independent EGFR degradation by probable perturbation of the Hsp90 chaperone complex TB Deb, AH Zuo, Y Wang, RJ Barndt, AK Cheema, S Sengupta, ... American Journal of Physiology-Cell Physiology 300 (5), C1139-C1154, 2011 | 24 | 2011 |
